Fedratinib

Fedratinib ATC Code L01EJ02 : Antineoplastic and immunomodulating agents - Antineoplastic drugs - Protein kinase inhibitors - Janus-associated kinase (JAK) inhibitors - Fedratinib
Fedratinib
RoutesOral
FDA Approval Date2019-08-16
Molecular FormulaC27H36N6O3S
Molecular Weight524.68 g/mol
CAS Number936091-26-8
Brand namesInrebic


ATC Codes

  1. Alimentary tract and metabolisma
  2. Blood and blood forming organs
  3. Cardiovascular system
  4. Dermatological drugs
  5. Genitourinary system and reproductive hormones
  6. Systemic hormonal preparations
  7. Antiinfectives for systemic use
  8. Antineoplastic and immunomodulating agents
  9. Musculoskeletal system
  10. Nervous system
  11. Antiparasitic products, insecticides and repellents
  12. Respiratory system
  13. Sensory organs
  14. Various ATC structures

The newly added categories

  1. Volanesorsen
  2. Casimersen
  3. Zanubrutinib
  4. Tivozanib
  5. Fedratinib
  6. Tucatinib
  7. Everolimus
  8. Abemaciclib
  9. Selumetinib
  10. Gefitinib